Health Care • Medical Specialities
$114.84 ▲ +0.84
(+0.74%)
MKT CAP: $5.42B • VOL: 583.3K
52W L $62 52W H $150
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$96
MEDIAN
$129
MEAN
$131
HIGH
$156
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE BLLN TAPE
BLLN // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $138.96 | $132.07 | 2025-02-14 | $104.50 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $144.70 | $135.51 | 2025-02-06 | $107.95 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $130.92 | $126.32 | 2025-01-29 | $110.25 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $117.14 | — | 2025-01-17 | $112.54 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $101.06 | $109.10 | 2025-01-09 | $102.21 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $136.66 | $119.43 | 2024-12-18 | $99.91 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $111.39 | $115.99 | 2024-12-04 | $106.80 | -4.3% | 48% | C |